SmartCella Holding AB gets FDA 510(k) clearance for Extroducer 2.0
SmartCella Holding AB received FDA 510(k) clearance for Extroducer 2.0, with prior indications for peripheral (including abdominal) tissues to deliver solutions into the extravascular space maintained.
0, keeping the same prior indications for peripheral tissues, including abdominal tissues, to deliver solutions into the extravascular space.